Effect of β‐Blockers Beyond 3 Years After Acute Myocardial Infarction

BACKGROUND: The optimal duration of β‐blocker therapy in patients with acute myocardial infarction (AMI) is unknown. We aimed to evaluate the late effect of β‐blockers in patients with AMI. METHODS AND RESULTS: We enrolled all consecutive patients who presented with AMI at Seoul National University...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jin Joo, Kim, Sun‐Hwa, Kang, Si‐Hyuck, Yoon, Chang‐Hwan, Cho, Young‐Seok, Youn, Tae‐Jin, Chae, In‐Ho, Choi, Dong‐Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866322/
https://www.ncbi.nlm.nih.gov/pubmed/29502101
http://dx.doi.org/10.1161/JAHA.117.007567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866322/
https://www.ncbi.nlm.nih.gov/pubmed/29502101
http://dx.doi.org/10.1161/JAHA.117.007567

Ejemplares similares